This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bridges, A. J. Articles by Spadone, D. P. Search for Related Content PubMed PubMed Citation Articles by Bridges, A. J. Articles by Spadone, D. P. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Raynaud's Disease Social Bookmarking                         What's this?

Tissue Plasminogen Activator Treatment of Digital Thrombosis in Severe Raynaud's Phenomenon— A Case Report

Department of Medicine, University of Missouri School of Medicine, Division of Immunology and Rheumatology, University of Missouri School of Medicine

Donald P. Spadone

Department of Surgery, University of Missouri School of Medicine, Division of Peripheral Vascular Surgery, University of Missouri School of Medicine, Columbia, Missouri

A thirty-one-year-old woman with long-standing mixed connective tissue dis ease and severe obliterative vasculopathy of the digits developed digital throm bosis of the first three digits of the left hand after using an electric blow dryer. The digits remained cool, cyanotic, and painful for thirty-six hours before medi cal evaluation. She was given 100 mg recombinant tissue plasminogen activator (TPA) intravenously. Within one hour the blood flow to the digits returned, accompanied by severe intermittent vasospasm of the digits. The thumb did not necrose; however, the second and third digits required amputation. No im provement was noted in the patient's baseline Raynaud's phenomenon or digital pressures of the uninvolved digits after TPA treatment. This case documents the usefulness of TPA for digital thrombosis in the setting of vasculopathy of con nective tissue disease. However, it does not support the utility of a single dose of TPA for severe Raynaud's phenomenon and recurrent digital ischemia in pa tients with connective tissue disease.

Angiology, Vol. 44, No. 7, 566-569 (1993)
DOI: 10.1177/000331979304400709


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?